# FDA Inspection 861652 - Novartis Pharma AG - December 05, 2013

Source: https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharma-ag/1b077692-a22d-4f7c-b346-0e1e6e392ae3
Source feed: FDA_Inspections

> FDA Inspection 861652 for Novartis Pharma AG on December 05, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 861652
- Company Name: Novartis Pharma AG
- Inspection Date: 2013-12-05
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1180833 - 2022-08-30](https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharma-ag/32e4f411-c7ba-4f89-859a-7bb61553cc6d)
- [FDA Inspection 1099919 - 2019-07-12](https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharma-ag/d744b62f-5e01-4ebd-b047-2f86a8d47a32)
- [FDA Inspection 1021086 - 2017-07-06](https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharma-ag/25132932-baad-4786-893f-6aa8f8fa697b)
- [FDA Inspection 916149 - 2015-01-14](https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharma-ag/4cb7840d-1d3d-40bf-bf48-7bb19d0c0dee)
- [FDA Inspection 793862 - 2012-07-26](https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharma-ag/e279d0a1-4400-41ba-8c4a-7f8ad3257901)

Company: https://www.globalkeysolutions.net/companies/novartis-pharma-ag/194ac641-5956-4430-9641-411cb975a51f

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c